• Launching PitchMI 2025 with Pete Martin

    September 8, 2025

    In this episode, we talk with Pete Martin, Director of Portfolio Management at the MSU Research Foundation, about the launch of PitchMI, a statewide startup pitch competition awarding up to $1.25 million in investment.

  • Inside 20 New Deals and Two New Funds with Jeff Wesley

    August 11, 2025

    In this episode, we talk with Jeff Wesley, Executive Director of Ventures at the MSU Research Foundation, about a high-impact quarter of startup activity and the launch of two new venture funds designed to strengthen Michigan’s early-stage ecosystem.

  • Reimagining Cancer Care and Clinical Trials with BAMF Health

    July 30, 2025

    In this episode, we talk with Chad Bassett, COO of BAMF Health, about how the company is transforming cancer care and clinical trials through advanced imaging, radiopharmaceuticals, and AI.

  • Building a University Startup Ecosystem with IU Ventures

    July 14, 2025

    In this episode, we talk with Jon Barada, vice president of IU Ventures, about how Indiana University is building a thriving startup ecosystem powered by alumni engagement and early-stage venture funding.

  • Transforming Clinical Trials with Ripple Science

    June 30, 2025

    In this episode, we talk with Peter Falzon, president and CEO of Ripple Science, a clinical trials software company that spun out of a university and now serves researchers around the world.

  • Advancing Grid-Scale Storage with Dr. Tom Guarr

    June 23, 2025

    In this episode, we talk with Dr. Tom Guarr, founder and CTO of Jolt Energy Storage Technologies, a Michigan-based startup developing organic compounds for redox flow batteries.

  • Engineering the Future of Quantum Computing with EeroQ

    June 2, 2025

    In this episode, we talk with Nick Farina and Dr. Johannes Pollanen of EeroQ, a quantum computing startup with roots at Michigan State University.

  • Advancing Killer Cell Immunotherapy with Mark Frohlich

    May 5, 2025

    In this episode, we talk with Dr. Mark Frohlich, CEO of Indapta Therapeutics, a biotech company working to make cancer treatment safer, more effective, and more accessible.